| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |